precancerous lesions of gastric cancer
Conditions
Interventions
control group:symptomatic treatment
treatment group:Xianglianhuazhuo granule
Sponsors
Hebei Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 69 Years
Inclusion criteria
Inclusion criteria: CAG diagnosis was confirmed by gastroscope and pathology. Gastroscopy and histopathological information were complete which were performed within 6 months before enrollment and without treatment. Eligible participants were male or female aged between 40 and 69 and provided informed consent voluntarily.
Exclusion criteria
Exclusion criteria: Patients with autoimmune gastritis peptic ulcer or upper gastrointestinal hemorrhage were excluded. Other exclusion criteria included high-grade intraepithelial neoplasia suspicion of gastric cancer malignant tumor severe organic diseases (such as cardiovascular and cerebrovascular diseases hepatopathy kidney diseases pulmonary diseases and blood diseases) medicine or ingredient allergies severe mental illness pregnancy lactation those involved in other clinical drug trials or had terminated their last drug study less than 1 month ago and those unable to cooperate with follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mucosal score under gastroscopy;PRO Scale score;markers for early gastric cancer screening;Histopathological score;Hp negative conversion rate;Evaluation of syndromic efficacy;Grading scale of syndrome differentiation elements of epigastric pain; | — |
Countries
China
Contacts
Public ContactQian Yang
Hebei Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed